UBS Group’s CapsoVision CV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$857K Buy
132,651
+125,354
+1,718% +$805K ﹤0.01% 5779
2026
Q2
$55.3K Sell
7,297
-57,859
-89% -$390K ﹤0.01% 7508
2026
Q1
$475K Buy
65,156
+59,569
+1,066% +$351K ﹤0.01% 6118
2025
Q4
$59.7K Buy
5,587
+3,620
+184% +$25.1K ﹤0.01% 7132
2025
Q3
$9.5K Buy
+1,967
New +$8.25K ﹤0.01% 8596

Other funds holding CV

UBS Group's CV Position: Q3 2026 in Review

UBS Group increased its CapsoVision (CV) stake by 1,718% in Q3 2026, buying an estimated $805K and bringing the position to 132,651 shares worth $857K. The position accounts for ﹤0.01% of the portfolio, ranked #5779.

UBS Group first reported a position in CV in Q3 2025 and has held it in 5 quarters since. 50 funds tracked by Wall St. Rank hold CV as of Q3 2026.

  • UBS Group held 132,651 shares of CapsoVision worth $857K as of Q3 2026.
  • UBS Group bought 125,354 CapsoVision shares in Q3 2026, an estimated $805K.
  • CapsoVision made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #5779 holding.
  • UBS Group first reported a position in CapsoVision in Q3 2025 and has held it in 5 quarters since.
  • 50 funds tracked by Wall St. Rank held CapsoVision as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.